What are the major opportunities in the Verluma market? What are the strategies for the Verluma market?

For detailed insights on the major opportunities and strategies in the Verluma market, Read More

How does the Verluma market relate to the overall economy and other similar markets?

For detailed insights on Verluma's relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Verluma industry?

For detailed insights on the mergers and acquisitions in the Verluma industry, Read More

What are the key dynamics influencing the Verluma market growth? SWOT analysis of the Verluma market.

For detailed insights on the key dynamics influencing the Verluma market growth and SWOT analysis of the Verluma industry, Read More

Item added to cart!

Published : December 2025

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Verluma Global Market Report 2025

Name: Verluma Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Indication (Cancer, Non-Cancer), By Distribution Channel (Hospital Pharmacies, Online Pharmacies), By End User (Adult, Geriatric)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Verluma Market?

Verluma is a radiolabeled monoclonal antibody fragment used in nuclear medicine to target carcinoembryonic antigen (CEA), a protein often overexpressed in Cancerous tumors. It helps detect and stage cancers, such as colorectal cancer, by binding to CEA-expressing tumor cells, allowing visualization through imaging techniques like SPECT.

The main types of indications for verluma are cancer and non-cancer. Cancer is a group of diseases characterized by uncontrolled cell growth and the potential to spread, with treatments such as verluma targeting specific cancer cells to reduce tumor growth and improve patient outcomes. It is distributed through various channels such as hospital pharmacies and online pharmacies and are cater to various end users including adult and geriatric.

Verluma Market Size and growth rate 2025 to 2029: Graph

What Is The Verluma Market Size 2025 And Growth Rate?

The verluma market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, increasing demand for imaging diagnostic procedures, growing geriatric population, increasing drug approvals, and growing healthcare infrastructure.

What Is The Verluma Market Growth Forecast?

The verluma market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the rising number of clinical trials, expansion of insurance coverage, increasing incidence of mental health disorders, growing prevalence of neurological disorders, and expansion of telemedicine services. Major trends in the forecast period include the integration of AI and digital health platforms, advancements in drug delivery technologies, advancements in genetic research, technological advancements in drug formulation, and the development of long-acting formulations.

Book your 30 minutes free consultation with our research experts

How Is The Verluma Market Segmented?

The verluma market covered in this report is segmented –

1) By Indication: Cancer; Non-Cancer

2) By Distribution Channel: Hospital Pharmacies; Online Pharmacies

3) By End User: Adult; Geriatric

What Is Driving The Verluma Market? Increasing Incidence Of Cancer Driving Growth In The Market

The increasing incidence of cancer is expected to propel the growth of the verluma market going forward. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells, which can invade surrounding tissues and potentially spread to other body parts through the blood and lymph systems. The rising cancer incidence is due to aging populations, lifestyle changes, and globalization of risk factors. Verluma is a therapeutic device that uses advanced technology, such as electromagnetic fields or other non-invasive methods, to potentially assist in cancer treatment by targeting and disrupting cancer cell growth, promoting healing, and improving the body's response to other therapies. For instance, according to the American Cancer Society Facts and Figures, a US-based professional organization, in 2024, over 2 million new cancer cases are expected to be diagnosed in the US, compared to the 1.9 million new cancer cases diagnosed in 2023. Therefore, the increasing incidence of cancer is driving the growth of verluma market.

What Is Driving The Verluma Market? Rising Demand For Diagnostic Imaging Procedures To Fuel Growth In The Market

The increasing demand for diagnostic imaging procedures is expected to propel the growth of the verluma market going forward. Diagnostic imaging procedures refer to various medical techniques used to create visual representations of the interior of a body for clinical analysis and medical intervention. The demand for diagnostic imaging procedures is rising due to the growing prevalence of chronic diseases, an increasing focus on early detection and preventive healthcare, and increased access to healthcare. Verluma improves diagnostic imaging procedures by enhancing image quality through advanced algorithms, enabling more accurate detection and analysis of medical conditions and improving patient outcomes. For instance, in November 2023, according to the National Health Service, a UK-based government department, in the year ending March 2023, England recorded 45.0 million imaging tests, reflecting a 2.2% increase compared to 44.0 million in 2022. Therefore, the increasing demand for diagnostic imaging procedures is driving the growth of the verluma market.

What Is Driving The Verluma Market? Impact Of Rising Healthcare Expenditure On The Growth Of The Market

The rise in healthcare expenditure is expected to propel the growth of the verluma market going forward. Healthcare expenditure refers to the total financial resources spent on healthcare services, including medical treatments, hospital care, pharmaceuticals, healthcare infrastructure, and preventive services. The rise in healthcare expenditure is attributed to factors such as an aging population, increasing prevalence of chronic diseases, advancements in medical technologies, and higher demand for healthcare services. Healthcare expenditure benefits Verluma by increasing demand for advanced healthcare technologies, including solutions that improve patient outcomes and operational efficiencies, as healthcare providers invest in innovative tools and systems. For instance, in December 2023, according to the Centers for Medicare & Medicaid Services, a US-based federal agency, the U.S. healthcare spending rose by 4.1% to a total of $4.5 trillion in 2022, an increase of 3.2% in 2021. Therefore, the rise in healthcare expenditure is driving the growth of the verluma market.

Who Are The Major Players In The Global Verluma Market?

Major companies operating in the verluma market are Boehringer Ingelheim International GmbH

Need data on a specific region in this market?

Request Regional Data

Regional Analysis For The Global Verluma Market

North America was the largest region in the verluma market in 2024. The regions covered in the verluma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the verluma market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Verluma Market?

The verluma market consists of sales of verluma injection and related products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Verluma Industry?

The verluma market research report is one of a series of new reports from The Business Research Company that provides verluma market statistics, including the verluma industry global market size, regional shares, competitors with the verluma market share, detailed verluma market segments, market trends, and opportunities, and any further data you may need to thrive in the verluma industry. This verluma market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Author : Abhilash Pyata

Verluma Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	Included ?
Revenue Forecast In 2034	Included ?
Growth Rate	Included ?
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The verluma market covered in this report is segmented – 1) By Indication: Cancer; Non-Cancer 2) By Distribution Channel: Hospital Pharmacies; Online Pharmacies 3) By End User: Adult; Geriatric
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Boehringer Ingelheim International GmbH
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Verluma Market Characteristics

3. Verluma Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Verluma Market Trends And Strategies

5. Verluma Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Verluma Growth Analysis And Strategic Analysis Framework

6.1. Global Verluma PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Verluma Market Growth Rate Analysis

6.4. Global Verluma Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Verluma Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Verluma Total Addressable Market (TAM)

7. Global Verluma Pricing Analysis & Forecasts

8. Verluma Market Segmentation

8.1. Global Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Cancer

Non-Cancer

8.2. Global Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospital Pharmacies

Online Pharmacies

8.3. Global Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Adult

Geriatric

9. Global Verluma Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Verluma Market Regional And Country Analysis

10.1. Global Verluma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Verluma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Verluma Market

11.1. Asia-Pacific Verluma Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Verluma Market

12.1. China Verluma Market Overview

12.2. China Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Verluma Market

13.1. India Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Verluma Market

14.1. Japan Verluma Market Overview

14.2. Japan Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Verluma Market

15.1. Australia Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Verluma Market

16.1. South Korea Verluma Market Overview

16.2. South Korea Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Verluma Market

17.1. Western Europe Verluma Market Overview

17.2. Western Europe Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Verluma Market

18.1. UK Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Verluma Market

19.1. Germany Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Verluma Market

20.1. France Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Verluma Market

21.1. Eastern Europe Verluma Market Overview

21.2. Eastern Europe Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Verluma Market

22.1. North America Verluma Market Overview

22.2. North America Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Verluma Market

23.1. USA Verluma Market Overview

23.2. USA Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Verluma Market

24.1. Canada Verluma Market Overview

24.2. Canada Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Verluma Market

25.1. South America Verluma Market Overview

25.2. South America Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Verluma Market

26.1. Middle East Verluma Market Overview

26.2. Middle East Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Verluma Market

27.1. Africa Verluma Market Overview

27.2. Africa Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Verluma Market Competitive Landscape And Company Profiles

28.1. Verluma Market Competitive Landscape

28.2. Verluma Market Company Profiles

28.2.1. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis

29. Global Verluma Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Verluma Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Verluma Market

32. Recent Developments In The Verluma Market

33. Verluma Market High Potential Countries, Segments and Strategies

33.1 Verluma Market In 2029 - Countries Offering Most New Opportunities

33.2 Verluma Market In 2029 - Segments Offering Most New Opportunities

33.3 Verluma Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Million

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Table 3: Global Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 4: Global Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 5: Global Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 6: Global Verluma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 7: Global Verluma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 8: Asia-Pacific, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 9: Asia-Pacific, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 10: Asia-Pacific, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 11: China, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 12: China, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 13: China, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 14: India, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 15: India, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 16: India, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 17: Japan, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 18: Japan, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 19: Japan, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 20: Australia, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 21: Australia, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 22: Australia, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 23: South Korea, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 24: South Korea, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 25: South Korea, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 26: Western Europe, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 27: Western Europe, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 28: Western Europe, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 29: UK, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 30: UK, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 31: UK, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 32: Germany, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 33: Germany, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 34: Germany, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 35: France, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 36: France, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 37: France, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 38: Eastern Europe, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 39: Eastern Europe, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 40: Eastern Europe, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 41: North America, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 42: North America, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 43: North America, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 44: USA, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 45: USA, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 46: USA, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 47: Canada, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 48: Canada, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 49: Canada, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 50: South America, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 51: South America, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 52: South America, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 53: Middle East, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 54: Middle East, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 55: Middle East, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 56: Africa, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 57: Africa, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 58: Africa, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 59: Boehringer Ingelheim International GmbH Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Million

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Figure 3: Global Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 4: Global Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 5: Global Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 6: Global Verluma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 7: Global Verluma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 8: Asia-Pacific, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 9: Asia-Pacific, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 10: Asia-Pacific, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 11: China, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 12: China, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 13: China, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 14: India, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 15: India, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 16: India, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 17: Japan, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 18: Japan, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 19: Japan, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 20: Australia, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 21: Australia, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 22: Australia, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 23: South Korea, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 24: South Korea, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 25: South Korea, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 26: Western Europe, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 27: Western Europe, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 28: Western Europe, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 29: UK, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 30: UK, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 31: UK, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 32: Germany, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 33: Germany, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 34: Germany, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 35: France, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 36: France, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 37: France, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 38: Eastern Europe, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 39: Eastern Europe, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 40: Eastern Europe, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 41: North America, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 42: North America, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 43: North America, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 44: USA, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 45: USA, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 46: USA, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 47: Canada, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 48: Canada, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 49: Canada, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 50: South America, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 51: South America, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 52: South America, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 53: Middle East, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 54: Middle East, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 55: Middle East, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 56: Africa, Verluma Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 57: Africa, Verluma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 58: Africa, Verluma Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 59: Boehringer Ingelheim International GmbH Financial Performance

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Skin Cancer Drugs Global Market Report 2025 – By Type (Actinic Keratoses (AK), Basal cell carcinoma (BCC), Squamous cell carcinoma (SCC), Melanoma), By Drug Class (Chemotherapy, Immunotherapy, Targeted Agents & Other Dru...

Pancreatic Cancer Drugs Global Market Report 2025 – By Type (Pancreatic Neuroendocrine Cancer Drugs, Pancreatic Exocrine Cancer Drugs), By Drug Combination (Single, Double, Triplet, Quadruplet), By End User (Hospital Pha...

Breast Cancer Drugs Global Market Report 2025 – By Type (Metastatic Breast Cancer, Triple Negative Breast Cancer, Others (Ductal Carcinoma Insitu, Invasive Ductal Carcinoma, Inflammatory Breast Cancer, Breast Cancer Duri...

Lung Cancer Drugs Global Market Report 2025 – By Drugs (Gemzar, Paraplatin, Taxotere, Navelbine, Avastin, Tarceva, Iressa, Other Drugs), By Disease Type (Small cell lung cancer (SCLC), Non-small cell lung cancer (NSCLC))...

Cancer Diagnostics Global Market Report 2025 – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast Cancer, Li...

Bladder Cancer Drugs Global Market Report 2025 – By Type (Non-Muscle-Invasive Bladder Cancer, Muscle-Invasive Bladder Cancer), By Application (Low-Grade Tumors, High-Grade Tumors), By Distribution Channel (Hospital Pharm...

Blood Cancer Drugs Global Market Report 2025 – By Blood Cancer Type (Leukemia, Lymphoma), By Drugs (Rituxan/Mabthera (Rituximab), Gleevec/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotin...

Frequently Asked Questions

What is the definition of the Verluma market?

Verluma is a radiolabeled monoclonal antibody fragment used in nuclear medicine to target carcinoembryonic antigen (CEA), a protein often overexpressed in cancerous tumors. It helps detect and stage cancers, such as colorectal cancer, by binding to CEA-expressing tumor cells, allowing visualization through imaging techniques like SPECT. For further insights on the Verluma market, request a sample here

How will the Verluma market drivers and restraints affect the market dynamics? What forces will shape the Verluma industry going forward?

The Verluma market major growth driver - Increasing Incidence Of Cancer Driving Growth In The Market. For further insights on the Verluma market, request a sample here

What is the forecast market size or the forecast market value of the Verluma market?

The Verluma market size has grown strongly in recent years. The verluma market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, increasing demand for imaging diagnostic procedures, growing geriatric population, increasing drug approvals, and growing healthcare infrastructure. The verluma market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the rising number of clinical trials, expansion of insurance coverage, increasing incidence of mental health disorders, growing prevalence of neurological disorders, and expansion of telemedicine services. Major trends in the forecast period include the integration of AI and digital health platforms, advancements in drug delivery technologies, advancements in genetic research, technological advancements in drug formulation, and the development of long-acting formulations. For further insights on the Verluma market, request a sample here

How is the Verluma market segmented?

The verluma market covered in this report is segmented –
1) By Indication: Cancer; Non-Cancer
2) By Distribution Channel: Hospital Pharmacies; Online Pharmacies
3) By End User: Adult; Geriatric For further insights on the Verluma market, request a sample here

Which region has the largest share of the Verluma market? What are the other regions covered in the report?

Who are the major players in the Verluma market?

Major companies operating in the verluma market are Boehringer Ingelheim International GmbH . For further insights on the Verluma market, request a sample here.

What are the key trends in the Verluma market?

Major trends in the Verluma market include . For further insights on the Verluma market, request a sample here.